EP Patent

EP1270001A1 — Pharmaceutical composition containing calcium acetate and calcium carbonate

Assigned to Individual · Expires 2003-01-02 · 23y expired

What this patent protects

A pharmaceutical composition useful for the treatment of hyperphosphatemia, in particular for decreasing the high blood concentration of phosphate which is present in uremic patients or in patients with chronic renal failure.

USPTO Abstract

A pharmaceutical composition useful for the treatment of hyperphosphatemia, in particular for decreasing the high blood concentration of phosphate which is present in uremic patients or in patients with chronic renal failure.

Drugs covered by this patent

Patent Metadata

Patent number
EP1270001A1
Jurisdiction
EP
Classification
—
Expires
2003-01-02
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.